Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)

China flag China · Delayed Price · Currency is CNY
8.60
-0.04 (-0.46%)
Oct 24, 2025, 3:04 PM CST
-0.46%
Market Cap4.84B
Revenue (ttm)1.09B
Net Income (ttm)24.08M
Shares Out562.87M
EPS (ttm)0.05
PE Ratio164.49
Forward PEn/a
Dividend0.05 (0.58%)
Ex-Dividend DateMay 19, 2025
Volume7,875,792
Average Volume15,619,548
Open8.89
Previous Close8.64
Day's Range8.58 - 8.89
52-Week Range5.42 - 11.98
Beta0.21
RSI40.79
Earnings DateOct 29, 2025

About SHE:300016

Beijing Beilu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. The company provides contrast agents, such as gadopentetate meglumine injection, gadobutrol injection, and gadobenate meglumine injection for MRI contrast; and iohexol injection, iopamidol injection, and iodixanol injection for CT contrast, as well as glimepiride and repaglinide tablets and jiuwei zhenxin granules. It also offers gadolinium-based agents, including gadopentetate dimeglumine and gadobutrol, as wel... [Read more]

Sector Healthcare
Founded 1992
Employees 1,173
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300016
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.